Claudia Cantoni

8PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyTumour immunologyHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Tumor Microenvironment and Immune Response Against Wilms Tumor: Evasion Mechanisms and Implications for Immunotherapeutic Approaches.

Claudia Cantoni, Valerio Gaetano Vellone, Barbara Cafferata

|Jul 18, 2024
Human NK cells and cancer.

Claudia Cantoni, Michela Falco, Massimo Vitale

|Apr 30, 2021
PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis.

Lorenzo Monteleone, Andrea Speciale, Giulia Elda Valenti

|Mar 24, 2021
Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells.

Claudia Cantoni, Martina Serra, Erica Parisi

|Sep 15, 2020
Escape of tumor cells from the NK cell cytotoxic activity.

Claudia Cantoni, Hannah Wurzer, Clément Thomas

|Sep 20, 2018
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor.

Silvia Gaggero, Maurizio Bruschi, Andrea Petretto

Pageof 2

Frequent Collaborators

4 joint publications

Massimo Vitale

4 joint publications

Lorenzo Moretta

3 joint publications

Cristina Bottino

2 joint publications

Andrea Petretto